ProCE Banner Activity

CRE-ating Success: How I Use Rapid Diagnostic Tests to Manage Carbapenem-Resistant Enterobacterales Bacteremia

Podcast Episodes

Hear Julie Ann Justo, PharmD, MS, FIDSA, BCPS, share her approach to treating CRE infections through a patient case, including a review of the changing epidemiology of CRE, contributing mechanisms of resistance, and current IDSA guidance recommendations based on the latest data.

Released: December 07, 2023

Share

Faculty

Julie Ann Justo

Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from bioMérieux, Inc.

bioMérieux, Inc.

Faculty Disclosure

Primary Author

Julie Ann Justo, PharmD, MS, FIDSA, BCPS

Clinical Pharmacist Lead – Infectious Diseases
Inpatient Pharmacy
Dartmouth Hitchcock Medical Center
Lebanon, New Hampshire

Julie Ann Justo, PharmD, MS, FIDSA, BCPS: consultant/advisor/speaker: Entasis Therapeutics, Gilead Sciences, Shionogi, Spero Therapeutics; stock/stock options: Vaxart.